节点文献

尿路感染病原菌对头孢曲松耐药的文献分析!

Analysis of Literatures about Drug Resistant Trend of Pathogens Causing Urinary Tract Infection to Ceftriaxone

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李苌清姚欣凯周岐新

【Author】 Li Changqing;Yao Xinkai;Zhou Qixin;Department of Pharmacy ,Chongqing Red Cross Hospital;Department of Clinical Pharmacy,Chongqing Medical University;

【机构】 重庆市红十字会医院药剂科重庆医科大学临床药学研究室

【摘要】 目的:调查我国近5年临床尿路感染病原菌对头孢曲松的耐药情况。方法:利用中国期刊全文数据库检索公开发表的关于尿路感染病原菌对头孢曲松耐药性监测的全部文献,分层计算尿路感染病原菌对头孢曲松的耐药率、敏感率,计算肯德尔相关系数(τ)。结果:共筛选出文献36篇,经统计,尿液中检出病原菌主要为大肠埃希菌(占64%)和肺炎克雷伯菌(占18%)。除奇异变形杆菌外,检出细菌对头孢曲松的耐药率均超过50%,而阴沟肠杆菌、鲍曼不动杆菌超过75%。根据肯德尔相关系数(τ)大小判断,大肠埃希菌和肺炎克雷伯菌对头孢噻肟和头孢曲松耐药呈高度相关,但不完全一致,菌株产ESBLs与头孢曲松耐药呈高度相关。结论:尿路感染分离革兰阴性菌对头孢曲松呈现出较高的耐药性,耐药机制以ESBLs为主,对于头孢曲松耐药菌感染选用头孢曲松酶抑制剂复方或许具有更好的针对性。

【Abstract】 Objective: To investigate drug resistance of pathogens causing urinary tract infection to ceftriaxone in the recent five years. Methods: the references related to drug resistance of pathogens causing urinary tract infection to ceftriaxone were retrieved through CNKI database. The resistance rates and sensibility rates of different types of bacteria were classified,calculated,and analyzed. And the Kendall correlation coefficient was also calculated. Results: 36 references were screened out,and statistical analysis showed that the main pathogen detected in the urine was Escherichia coli( 64%),followed by Klebsiella pneumoniae( 18%). In addition to Proteus mirabilis,the drug resistance rate of detected bacterias was over 50% to ceftriaxone,while the drug resistance rates of Enterobacter cloacae,Acinetobacter baumannii and Pseudomonas aeruginosa were more than 75%. According to the Kendall correlation coefficient( τ),the resistance rates of Escherichia coli and Klebsiella pneumoniae to cefotaxime and ceftriaxone were highly correlated,especially that from the ESBLs-producing Escherichia coli and Klebsiella pneumonia. Conclusion: The resistance rates of pathogens causing urinary tract infection to ceftriaxone displayed an upward tendency. The mechanism of resistance to strains was mainly involved in producing ESBLs. Which indicated that ceftriaxone and β-lactamase compound preparations may become the best choice for the treatment of the infection of ceftriaxone drug-resistant strains.

【基金】 国家十二五“重大新药创制”科技重大专项(编号:2011ZX09201-101-03);重庆市卫生局医学科研重点项目(编号:2012-1-105)
  • 【文献出处】 药物流行病学杂志 ,Chinese Journal of Pharmacoepidemiology , 编辑部邮箱 ,2015年12期
  • 【分类号】R446.5
  • 【被引频次】2
  • 【下载频次】55
节点文献中: 

本文链接的文献网络图示:

本文的引文网络